Clinical trial
Treatment of Hyperuricemia in Patients With Heart Failure
NCT00422318 · Tottori University Hospital, Other · Completed
Key facts
| NCT number | NCT00422318 |
|---|---|
| Title | Treatment of Hyperuricemia in Patients With Heart Failure |
| Official title | Hyperuricemia and the Effects of the Uricosuric Agents Benzbromarone in Patients With Chronic Heart Failure |
| Lead sponsor | Tottori University Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Heart Failure, Hyperuricemia |
| Intervention type | Drug |
| Interventions | Benzbromarone (drug) |
| Start date | Jan 1, 2004 |
| Completion | Dec 1, 2005 |
| First posted | Jan 15, 2007 |
| Last update posted | Jan 15, 2007 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: